Promotion of neovascularization around hollow fiber bioartificial organs using biologically active substances

ASAIO Journal

Volumn 45, Issue 1, 1999, Pages 37-40

  Hunter, Stephen K ^a,b   Kao, Jay M ^c   Wang, Ye ^c   Benda, Jo Ann ^b   Rodgers, V G J ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c IA United States   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMODYNAMICS; IMPLANTS (SURGICAL); PLASTIC FILAMENTS; POLYPEPTIDES; POLYSULFONES; VINYL RESINS;

ENDOTHELIAL CELL GROWTH FACTOR; NEOVASCULARIZATION;

ARTIFICIAL ORGANS;

ENDOTHELIAL CELL GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL ORGAN; IMMUNOHISTOCHEMISTRY; IMPLANT; NONHUMAN; OXYGEN TRANSPORT; RAT;

EID: 0032601367     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199901000-00009     Document Type: Article

References (5)

1. Colton CK: Engineering challenges in cell-encapsulation technology. Trends Biotechnol 14: 158-162, 1996.
2. Colton CK, Avgoustiniatos ES: Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng 113: 152-170, 1991.
3. Thomas KA: Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271: 603-606, 1996.
4. Lanza RP, Chick WL: Encapsulated cell transplantation. Transplant Rev 9-217, 1995.
5. Bonner-Weir S, Orci S: New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31: 883-889, 1982.